Advertisement
Person › Details
Natalia Baranowska (Ryvu Therapeutics S.A. (WSE: RVU))
Baranowska, Natalia (Selvita 201412 Media Contact)
Organisation | Ryvu Therapeutics S.A. (WSE: RVU) | |
Former/major organisation | Selvita S.A. (WSE:SLV) | |
Group | Selvita (Group) | |
Product | public relations / investor relations / marcom (services) | |
Product 2 | drug development | |
Record changed: 2023-03-05 |
Advertisement
More documents for Natalia Baranowska
- [1] Ryvu Therapeutics S.A.. (12/14/21). "Press Release: Ryvu Announces Option to License Inflammation Program Exercised by Galapagos NV". Tübingen, Houston, TX & New York, NY....
- [2] Selvita S.A.. (8/8/17). "Press Release: Selvita and The Leukemia & Lymphoma Society Announce Partnership to Advance SEL120 into Phase I for AML Patients". Krakow & Rye Brook....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement
» top